Literature DB >> 34926199

Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma.

Rui Liu1, Nan Wang1, Hong Zhang1, Xin Ge1, Jian-Min Ma1.   

Abstract

AIM: To monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized.
METHODS: In this retrospective, comparative case series, clinical records from 109 cases of LGPA treated chiefly at the same institution between November 2009 and May 2019 were reviewed. All 109 patients underwent surgery, histopathological examination, and imaging examination. For patients who underwent surgery for the first time, LGPA could be resected completely, including tumor and capsule tissues, using a surgical approach via the eyebrow arch or double eyelid crease.
RESULTS: The ratio of males to females was 1:1.60, the ages ranged from 19 to 74 years old with a mean age of 43.64±13.07 years old, and the ratio of left to right eyes was 1:1.37. A total of 109 patients underwent surgical excision and five of these received radiotherapy after malignant transformation. Of these patients, 15 were lost to follow up within the April 1, 2020 deadline and 1 was diagnosed as a recurring pathology. The 5-year recurrence rate for 86 patients who underwent initial surgery was 7.27%. Single factor analysis revealed that the course of disease, bone destruction, invasion of surrounding tissues, tumor size, capsule integrity, and expression of Ki-67 were statistically significant (P<0.05). Binomial Logistic regression analysis showed that capsule integrity was a risk factor influencing recurrence (P=0.008).
CONCLUSION: LGPA has a risk of recurrence and potential for malignant transformation. Complete removal of the tumor and capsule in the initial surgery is a key factor in preventing recurrence. International Journal of Ophthalmology Press.

Entities:  

Keywords:  lacrimal gland; malignant transformation; pleomorphic adenoma; prognosis; treatment

Year:  2021        PMID: 34926199      PMCID: PMC8640764          DOI: 10.18240/ijo.2021.12.07

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

Review 1.  Maxillofacial diagnostic features of the enigmatic metastasizing pleomorphic adenoma.

Authors:  F L Shoukair; A Maly; T K Haran; N Hirshoren; J Abu Tair
Journal:  Int J Oral Maxillofac Surg       Date:  2020-01-28       Impact factor: 2.789

2.  Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.

Authors:  Marisa Cristina Leite Santos Genelhu; Helenice Gobbi; Fernando Augusto Soares; Antônio Hugo José Froes de Marques Campos; Carlos Alberto Ribeiro; Geovanni Dantas Cassali
Journal:  Oral Oncol       Date:  2005-10-26       Impact factor: 5.337

3.  Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.

Authors:  Nora Katabi; Daniel Gomez; David S Klimstra; Diane L Carlson; Nancy Lee; Ronald Ghossein
Journal:  Hum Pathol       Date:  2010-03-24       Impact factor: 3.466

4.  Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.

Authors:  Kimihide Kusafuka; Takuya Kawasaki; Tetsuro Onitsuka; Noriko Hamaguchi; Kotaro Morita; Takashi Mukaigawa; Yukio Nishiya; Tomoyuki Kamijo; Yoshiyuki Iida; Takashi Nakajima; Takashi Sugino
Journal:  Head Neck Pathol       Date:  2018-11-27

5.  Extra-capsular dissection for benign parotid tumours.

Authors:  E A Shehata
Journal:  Int J Oral Maxillofac Surg       Date:  2010-01-06       Impact factor: 2.789

6.  Immunohistochemical features of lacrimal gland epithelial tumors.

Authors:  Pia R Mendoza; Frederick A Jakobiec; Jeffrey F Krane
Journal:  Am J Ophthalmol       Date:  2013-08-20       Impact factor: 5.258

7.  A Rare Pediatric Case of Lacrimal Gland Pleomorphic Adenoma.

Authors:  Justin R Bryant; Esperanza Mantilla-Rivas; Monica Manrique; Robert F Keating; Narieman A Nik; Albert K Oh; Gary F Rogers
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-09-23

8.  Pleomorphic adenoma of lacrimal gland.

Authors:  Ozcan Binatli; Onur Yaman; Nail Ozdemir; Işın Gökçöl Erdoğan
Journal:  J Surg Case Rep       Date:  2013-10-22

Review 9.  Pleomorphic adenoma of the lacrimal gland: A review with updates on malignant transformation and molecular genetics.

Authors:  William Harrison; Patricia Pittman; Thomas Cummings
Journal:  Saudi J Ophthalmol       Date:  2018-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.